Levin Capital Strategies, L.P. Purchases 50,987 Shares of Fluidigm Co. (FLDM) Stock

Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. bought 50,987 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The shares were bought at an average cost of $5.96 per share, for a total transaction of $303,882.52. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Thursday, February 1st, Levin Capital Strategies, L.P. bought 152,891 shares of Fluidigm stock. The shares were bought at an average cost of $6.18 per share, for a total transaction of $944,866.38.
  • On Tuesday, January 23rd, Levin Capital Strategies, L.P. bought 6,871 shares of Fluidigm stock. The shares were bought at an average cost of $6.57 per share, for a total transaction of $45,142.47.
  • On Tuesday, January 16th, Levin Capital Strategies, L.P. bought 887 shares of Fluidigm stock. The shares were bought at an average cost of $6.68 per share, for a total transaction of $5,925.16.
  • On Wednesday, January 10th, Levin Capital Strategies, L.P. bought 100,576 shares of Fluidigm stock. The shares were bought at an average cost of $6.34 per share, for a total transaction of $637,651.84.
  • On Wednesday, January 3rd, Levin Capital Strategies, L.P. bought 29 shares of Fluidigm stock. The shares were bought at an average cost of $6.63 per share, for a total transaction of $192.27.
  • On Friday, December 28th, Levin Capital Strategies, L.P. bought 30 shares of Fluidigm stock. The shares were bought at an average cost of $5.82 per share, for a total transaction of $174.60.
  • On Friday, December 29th, Levin Capital Strategies, L.P. bought 11,230 shares of Fluidigm stock. The shares were bought at an average cost of $5.94 per share, for a total transaction of $66,706.20.
  • On Wednesday, December 27th, Levin Capital Strategies, L.P. bought 27,100 shares of Fluidigm stock. The shares were bought at an average cost of $5.88 per share, for a total transaction of $159,348.00.
  • On Friday, December 15th, Levin Capital Strategies, L.P. bought 24,175 shares of Fluidigm stock. The shares were bought at an average cost of $5.84 per share, for a total transaction of $141,182.00.
  • On Tuesday, December 12th, Levin Capital Strategies, L.P. bought 18,569 shares of Fluidigm stock. The shares were bought at an average cost of $5.84 per share, for a total transaction of $108,442.96.

Fluidigm Co. (FLDM) traded down $0.16 during mid-day trading on Tuesday, reaching $5.75. The company’s stock had a trading volume of 245,751 shares, compared to its average volume of 179,038. The company has a debt-to-equity ratio of 5.00, a quick ratio of 2.46 and a current ratio of 3.02. Fluidigm Co. has a twelve month low of $2.52 and a twelve month high of $7.05. The stock has a market capitalization of $223.00, a PE ratio of -2.58 and a beta of 3.24.

Hedge funds have recently bought and sold shares of the business. Bank of New York Mellon Corp boosted its position in Fluidigm by 70.0% in the third quarter. Bank of New York Mellon Corp now owns 370,427 shares of the medical research company’s stock worth $1,867,000 after purchasing an additional 152,588 shares during the last quarter. Russell Investments Group Ltd. boosted its position in Fluidigm by 46.8% in the third quarter. Russell Investments Group Ltd. now owns 3,447,491 shares of the medical research company’s stock worth $17,370,000 after purchasing an additional 1,099,072 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in Fluidigm in the third quarter worth $123,000. Neuberger Berman Group LLC boosted its position in Fluidigm by 181.6% in the third quarter. Neuberger Berman Group LLC now owns 5,213,481 shares of the medical research company’s stock worth $26,276,000 after purchasing an additional 3,362,100 shares during the last quarter. Finally, Virtu KCG Holdings LLC purchased a new position in Fluidigm in the second quarter worth $105,000. 93.83% of the stock is currently owned by institutional investors and hedge funds.

Separately, ValuEngine raised Fluidigm from a “strong sell” rating to a “sell” rating in a research report on Monday, October 23rd.

COPYRIGHT VIOLATION NOTICE: “Levin Capital Strategies, L.P. Purchases 50,987 Shares of Fluidigm Co. (FLDM) Stock” was reported by American Banking News and is owned by of American Banking News. If you are viewing this story on another publication, it was illegally copied and republished in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/02/06/levin-capital-strategies-l-p-purchases-50987-shares-of-fluidigm-co-fldm-stock.html.

Fluidigm Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply